Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indoleamine 2,3-dioxygenase 1 limits hepatic inflammatory cells recruitment and promotes bile duct ligation-induced liver fibrosis
Chan Mo, Shuwen Xie, Bin Liu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 20

Showing 20 citing articles:

Si-Wu-Tang attenuates liver fibrosis via regulating lncRNA H19-dependent pathways involving cytoskeleton remodeling and ECM deposition
Jiaorong Qu, Xiaoyong Xue, Zhixing WANG, et al.
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 1, pp. 31-46
Closed Access | Times Cited: 8
Caveolin-1 is critical for hepatic iron storage capacity in the development of nonalcoholic fatty liver disease
Deng Guang-hui, Chaofeng Wu, Yunjia Li, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 15
Metabolic profiling of tryptophan pathways: Implications for obesity and metabolic dysfunction‐associated steatotic liver disease
Carmen Arto, Elena Cristina Rusu, Helena Clavero‐Mestres, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 11
Open Access | Times Cited: 6
Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice
Lin Zhang, Haibo Zhang, Gu Jin-Hua, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109433-109433
Closed Access | Times Cited: 20
Indoleamine 2, 3-dioxygenase 1 activation in macrophage exacerbates hepatic ischemia-reperfusion injury by triggering hepatocyte ferroptosis
Shuoyi Ma, Junjie Li, Haixin Ye, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111692-111692
Closed Access | Times Cited: 4
Integrated UHPLC-Q-Exactive Orbitrap HRMS and Serum Pharmacochemistry for the Investigation of Anti-hepatic Fibrosis Effect of BaoGanNing Decoction
Kaili Deng, Min Li, Liangliang Xiang, et al.
Phytomedicine (2025) Vol. 137, pp. 156363-156363
Closed Access
The crucial function of IDO1 in pulmonary fibrosis: From the perspective of mitochondrial fusion in lung fibroblasts and targeted molecular inhibition
Lei Wang, Shanchun Ge, Ye Zhang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Naringin ameliorates liver fibrosis in zebrafish by modulating IDO1-mediated lipid metabolism and inflammatory infiltration
Mengchen Qin, Junjie Li, Yan-Tao Zheng, et al.
Food & Function (2023) Vol. 14, Iss. 23, pp. 10347-10361
Closed Access | Times Cited: 9
Kynurenines as a Novel Target for the Treatment of Inflammatory Disorders
Adrian Mor, Anna Tankiewicz‐Kwedlo, Marianna Ciwun, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1259-1259
Open Access | Times Cited: 3
Si-Wu-Tang ameliorates bile duct ligation-induced liver fibrosis via modulating immune environment
Zhi Ma, Xiaoyong Xue, Jinzhao Bai, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113834-113834
Open Access | Times Cited: 13
Roles and therapeutic targeting of dendritic cells in liver fibrosis
Bingyu Wang, Liuxin Yang, Xingxing Yuan, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 6, pp. 647-654
Closed Access | Times Cited: 2
Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy
Xiaohong Zheng, Xia Zhou, Gang Ma, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Oxyberberine suppressed the carbon tetrachloride-induced liver fibrosis by inhibiting liver inflammation in a sirtuin 3-dependent manner in mice
Sicheng Zhao, Jidan Li, Xiaoxiao Xing, et al.
International Immunopharmacology (2023) Vol. 116, pp. 109876-109876
Closed Access | Times Cited: 4
Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells
Qiuyun Yi, Jinxian Yang, Ying Wu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
T cells in pancreatic cancer stroma: Tryptophan metabolism plays an important role in immunoregulation
Ting Yang, Qiaoqi Li, Yongmei Liu, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 17, pp. 2701-2703
Open Access | Times Cited: 3
Inhibition of ERO1a and IDO1 improves dendritic cell infiltration into pancreatic ductal adenocarcinoma
Apple H.M. Tay, Riccardo Cinotti, Newman Sui Kwan Sze, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Emerging Roles on Immunological Effect of Indoleamine 2,3-Dioxygenase in Liver Injuries
Lingyan Xu, Jiawei Ling, Chang Su, et al.
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 4
The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro
Shanshan Wang, Fei Ye, Qingjia Ren, et al.
Journal of Ethnopharmacology (2023) Vol. 319, pp. 117283-117283
Closed Access | Times Cited: 1
Neurotensin contributes to cholestatic liver disease potentially modulating matrix metalloprotease-7
Hongxia Zhao, Xinbei Tian, Bo Wu, et al.
The International Journal of Biochemistry & Cell Biology (2024) Vol. 170, pp. 106567-106567
Closed Access
Bioinformatics and next generation data analysis reveals the potential role of inflammation in sepsis and its associated complications
Basavaraj Vastrad, Chanabasayya Vastrad
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top